Abstract |
Interleukin-2 (IL-2) after autologous stem cell transplantation (SCT) is being explored as a way of reducing relapse. To determine the immunostimulating effect of low-dose subcutaneous IL-2 following SCT, the in vitro and in vivo activity of patient peripheral blood mononuclear cells (PBMNC) was studied. A predominantly natural killer (NK) lymphocytosis was induced and sustained throughout most of the IL-2 treatment period. The in vivo primed PBMNC had enhanced lytic activity against a variety of tumor targets. The in vitro cytotoxicity of in vivo IL-2-primed PBMNC could be increased further by overnight incubation in 1000 U/ml IL-2. The SU-DHL-4 B cell lymphoma xenotransplantation model was used as an in vivo system for testing the efficacy of cellular therapy. PBMNC obtained by apheresis from autografted patients that had received post-transplant IL-2 for 35-42 days were infused i.v. into SU-DHL-4 bearing C.B-17 severe combined immunodeficient (SCID) mice. Control mice died of disseminated lymphoma at a median of 35.2 days, while murine recipients of in vivo activated human PBMNC cells from IL-2-treated SCT patients survived significantly longer (58.2 days). The in vivo effect of human PBMNC on survival of tumor-bearing mice correlated well with their in vitro cytolytic activity as assessed by 51Cr release assays, indicating that the SCID SU-DHL-4 lymphoma model can be utilized reliably to test the efficacy of cellular therapy in vivo.
|
Authors | E Katsanis, D J Weisdorf, J S Miller |
Journal | Bone marrow transplantation
(Bone Marrow Transplant)
Vol. 22
Issue 2
Pg. 185-91
(Jul 1998)
ISSN: 0268-3369 [Print] England |
PMID | 9707028
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
|
Topics |
- Administration, Cutaneous
- Animals
- Hematopoietic Stem Cell Transplantation
- Humans
- Immunotherapy, Adoptive
- Interleukin-2
(administration & dosage)
- Killer Cells, Natural
(immunology, transplantation)
- Lymphoma, B-Cell
(blood, immunology, therapy)
- Mice
- Mice, SCID
- Neoplasms, Experimental
(immunology, therapy)
- Transplantation, Autologous
|